
Iran ready to export medicines to Venezuela
pharmafile | February 25, 2019 | News story | Sales and Marketing | FDA, Iran, Venezuela, biotech, global, pharma
The chairman of the Iranian Food and Drug Administration (FDA) Mehdi Pirsalehi, has said that Iran is ready to export medicines and medical equipment to Venezuela.
Building on a previous agreement between the two countries from early last year, the statement signals a readiness for greater cooperation between Venezuela and Iran.
The medical exports will be undertaken within the framework of the previously signed agreement.
The news comes as Mostafa Ghanei, Chairman of the Biotechnology Development Council announced that Iran now exports drugs to 17 countries.
“No one could imagine that a country which used to be a major importer of biopharmaceuticals is now an exporter of them,” he said.
Meanwhile Danish firm Novo Nordisk is set to continue production in Iran through the E3 trade vehicle INSTEX established in January 2019. Headquartered in Paris, the special-purpose vehicle (SPV) was established by Germany, France and Britain in order to facilitate non-dollar trade with Iran in the face of US sanctions.
Louis Goss
Related Content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance
Microbial Resource Management (MRM) Health has announced that its lead programme, MH002, has received Investigational …

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary …

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed …





